Author details

Full Name

Jane E Minturn

Affiliation

ORCID

Career Start Year

1990

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37978951	Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.	J Clin Oncol	2024
37174087	Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study.		2023
37218333	ZFTA-fused supratentorial ependymoma with a novel fusion partner, DUX4.	J Neuropathol Exp Neurol	2023
37314947	The Impact of Proactive Gastrostomy Tube Placement on Treatment-related Outcomes in Young Children With High-grade Central Nervous System Tumors.		2023
37126021	Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency.	Clin Cancer Res	2023
35148393	Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry.	Neuro Oncol	2022
35552452	Characteristics of children â¿¤36 months of age with DIPG: A report from the international DIPG registry.	Neuro Oncol	2022
35235547	Guideline for Children With Cancer Receiving General Anesthesia for Procedures and Imaging.	J Pediatr Hematol Oncol	2022
34668975	Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry.	Neuro Oncol	2022
34605383	Reduced Fusiform Gyrus Activation During Face Processing in Pediatric Brain Tumor Survivors.	Journal of the International Neuropsychological Society	2022
34540703	A Pilot Study of Low-Dose Craniospinal Irradiation in Patients With Newly Diagnosed Average-Risk Medulloblastoma.	Front Oncol	2021
34383370	Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors.	Pediatric Blood and Cancer	2021
32506137	MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry.	Neuro Oncol	2020
31999166	Diminished social attention in pediatric brain tumor survivors: Using eye tracking technology during naturalistic social perception.	Neuropsychology	2020
32523649	Phase I study of vemurafenib in children with recurrent or progressive BRAF<sup>V600E</sup> mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002).	Oncotarget	2020
31512390	Tumor bed proton irradiation in young children with localized medulloblastoma.	Pediatric Blood and Cancer	2019
30982198	Clinical diagnosis of attention-deficit/hyperactivity disorder in survivors of pediatric brain tumors.	J Neurooncol	2019
31133068	Clinical utility of custom-designed NGS panel testing in pediatric tumors.	Genome Med	2019
31456142	Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.	J Neurooncol	2019
31512931	Risk of brainstem necrosis in pediatric patients with central nervous system malignancies after pencil beam scanning proton therapy.	Acta Oncol	2019
29746225	Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.	J Clin Oncol	2018
28612973	Survivors of childhood brain tumors and their caregivers: transition to adulthood.	Dev Med Child Neurol	2017
28821206	Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study.	Neuro Oncol	2017
28585383	19-Year-Old Male with Headaches and a Possible Seizure.	Brain Pathol	2017
26235452	Carboplatin Rechallenge After Hypersensitivity Reactions in Pediatric Patients With Low-Grade Glioma.	Pediatr Blood Cancer	2016
27302514	Neuroplastic Response After Radiation Therapy for Pediatric Brain Tumors: A Pilot Study.	International Journal of Radiation Oncology Biology Physics	2016
23385535	Network-based analysis of multivariate gene expression data.	Methods in Molecular Biology	2013
23440592	Gliomas in children.	Current Treatment Options in Neurology	2013
21990266	Clinical significance of NTRK family gene expression in neuroblastomas.	Pediatric Blood and Cancer	2012
22623209	AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts.	Cancer Chemotherapy and Pharmacology	2012
21968943	A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study.	J Neurooncol	2012
21602726	A rare case of ectopic recurrence of a craniopharyngioma diagnosed 17 years after initial presentation.	Journal of Pediatric Hematology/Oncology	2011
21484309	Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.	Cancer Chemother Pharmacol	2011
21128244	Differential aminoacylase expression in neuroblastoma.	International Journal of Cancer	2011
21163964	The genetic landscape of the childhood cancer medulloblastoma.	Science	2011
21340605	Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.	Cancer Chemother Pharmacol	2011
21339191	Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas.	Neuro Oncol	2011
21108437	A phase II study of metronomic oral topotecan for recurrent childhood brain tumors.	Pediatr Blood Cancer	2011
21419569	The effect of P75 on Trk receptors in neuroblastomas.	Cancer Letters	2011
20179224	Lestaurtinib enhances the antitumor efficacy of chemotherapy in murine xenograft models of neuroblastoma.	Clin Cancer Res	2010
19417027	Trk receptor expression and inhibition in neuroblastomas.	Clinical Cancer Research	2009
16267010	Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor.	Cancer Res	2005
12438236	Resistance to chemotherapy mediated by TrkB in neuroblastomas.	Cancer Research	2002
7558240	Isoform-specific expression of sodium channels in astrocytes in vitro: immunocytochemical observations.	GLIA	1995
7472434	TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C. elegans gene involved in axon outgrowth.	J Neurosci	1995
7636019	Early postmitotic neurons transiently express TOAD-64, a neural specific protein.	J Comp Neurol	1995
8380514	Dynamic aspects of sodium channel expression in astrocytes.	Advances in neurology	1993
1324888	Sodium channel expression in optic nerve astrocytes chronically deprived of axonal contact.	GLIA	1992
1337617	The expression of sodium channels in astrocytes in situ and in vitro.	Progress in Brain Research	1992
1789588	Cell coupling is restricted to subpopulations of astrocytes cultured from rat hippocampus and optic nerve.	Annals of the New York Academy of Sciences	1991